Home > Income Statement > ERIS LIFESCIENCES

ERIS LIFESCIENCES
Revenue

    Back to Income Statement
ERIS LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ERIS LIFESCIENCES
Please provide your vote to see the results

ERIS LIFESCIENCES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹2,009 Cr₹16,851 Cr₹1,347 Cr₹1,212 Cr₹1,074 Cr

What is the latest Revenue of ERIS LIFESCIENCES ?

The latest Revenue ratio of ERIS LIFESCIENCES is ₹2,009 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹2,009 Cr
Mar2024₹16,851 Cr
Mar2023₹1,347 Cr
Mar2022₹1,212 Cr
Mar2021₹1,074 Cr

How is Revenue of ERIS LIFESCIENCES Trending?

Years Revenue % Change
Mar2025 ₹2,009 Cr
-88.08
Mar2024 ₹16,851 Cr
1,151.00
Mar2023 ₹1,347 Cr
11.15
Mar2022 ₹1,212 Cr
12.83
Mar2021 ₹1,074 Cr -

Compare Revenue of peers of ERIS LIFESCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ERIS LIFESCIENCES ₹24,054.3 Cr 0.7% 8.7% 72.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,872.0 Cr -2.1% 1.7% 6.3% Stock Analytics
DIVIS LABORATORIES ₹177,609.0 Cr -1.5% 1.5% 46.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,277.0 Cr 2.5% 11.2% 15.3% Stock Analytics
CIPLA ₹119,184.0 Cr -1% -1.7% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,116.0 Cr -0.1% -5% -5.6% Stock Analytics


ERIS LIFESCIENCES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ERIS LIFESCIENCES

0.7%

8.7%

72.4%

SENSEX

-0.1%

1%

1.8%


You may also like the below Video Courses